Genprex
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Genprex and other ETFs, options, and stocks.About GNPX
Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company product is REQORSA immunogen therapy drug for non-small cell lung cancer.
CEORyan M. Confer
CEORyan M. Confer
Employees15
Employees15
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded2009
Founded2009
Employees15
Employees15
GNPX Key Statistics
Market cap4.96M
Market cap4.96M
Price-Earnings ratio-0.04
Price-Earnings ratio-0.04
Dividend yield—
Dividend yield—
Average volume178.78K
Average volume178.78K
High today$2.24
High today$2.24
Low today$2.03
Low today$2.03
Open price$2.20
Open price$2.20
Volume198.80K
Volume198.80K
52 Week high$55.00
52 Week high$55.00
52 Week low$2.03
52 Week low$2.03
Stock Snapshot
As of today, Genprex(GNPX) shares are valued at $2.20. The company's market cap stands at 4.96M, with a P/E ratio of -0.04.
During the trading session on 2025-12-21, Genprex(GNPX) shares reached a daily high of $2.24 and a low of $2.03. At a current price of $2.20, the stock is +8.4% higher than the low and still -1.8% under the high.
Trading activity shows a volume of 198.8K, compared to an average daily volume of 178.78K.
The stock's 52-week range extends from a low of $2.03 to a high of $55.00.
The stock's 52-week range extends from a low of $2.03 to a high of $55.00.
People also own
Based on the portfolios of people who own GNPX. This list is generated using Robinhood data, and it’s not a recommendation.